Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06687850 · ClinicalTrials.gov registry record · NA
Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders
A NA study, sponsored by University of Arkansas, Fayetteville.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT06687850: Completed NA study, sponsored by University of Arkansas, Fayetteville.
NCT06687850 is a NA study that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06687850, a NA study, has completed, sponsored by University of Arkansas, Fayetteville.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the effect of animal-assisted therapy (AAT) on prosocial behavior and emotional regulation in children with developmental delay, behavioral concerns, or autism spectrum disorder. Service dog use in the pediatric population who have these concerns is increasing and more studies are indicated to determine best practice for incorporating canines into traditional therapy sessions to enhance therapeutic outcomes. The hypothesis for this study is that inclusion of the canine will enhance therapy sessions and produce a lasting effect on prosocial behavior and emotional regulation after AAT sessions have concluded.
Primary Outcome
* Child's caregiver: child's legal guardian or representative over age 16 years who was present during AAT sessions. * Therapist: Canine handler and therapist conducting the sessions. * Canine: Canine trained as a therapy and service dog. * Control objects: Defined as any inanimate object that is included in the study as a control condition for the canine
Interventions
- BEHAVIORAL animal assisted therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT06687850 record still lists
NCT06687850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which animal assisted therapy is the first listed.
NCT06687850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06687850 about?
NCT06687850 is a clinical study titled "Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders". The purpose of this research is to evaluate the effect of animal-assisted therapy (AAT) on prosocial behavior and emotional regulation in children with developmental delay, behavioral concerns, or autism spectrum disorder. Service dog use in the pediatric population who have these concerns is increa...
What is the current status of trial NCT06687850?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-05-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT06687850?
The interventions under investigation include: animal assisted therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06687850?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06687850's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI